abstract |
The present invention relates to at least one novel human anti-amyloid antibody, comprising isolated nucleic acids that encode at least one anti-amyloid antibody, amyloid, vectors, host cells, transgenic animals or plants, and methods for making and using them, comprising therapeutic compositions, methods and devices. |